World Health Summit
The Moment is Now: Unlocking New Capital for Women’s Health Beyond Aid | PD 02
updated
Both G7 and G20 have addressed the challenges emerging from the COVID-19 pandemic, have institutionalized cooperation between health and financial sectors, and initiated the new Pandemic Fund. Recently they have begun to increase their outreach to Low- and Middle-Income Countries (LMICs) to ensure the voices of particularly affected countries and regions are included. Equity must be a central pillar of the discussions as countries are unequally affected by crises, with the most vulnerable countries, regions and groups hit hardest.
The increasing health activities of the G7 and G20 merit a reflection on the plans and program of work of the two upcoming presidencies and the challenges they face.
At a time when global attention is shifting towards improving the way we prevent and respond to future pandemics, this session will focus on the importance of equitable access to health innovations.
In collaboration with governments of donor and implementing countries, as well as manufacturers and communities, expanding the availability and affordability of quality assured health products is in everyone's interest. Ensuring equity in each stage of the continuum, from the incentive to develop and introduce new tools, to supply chain and last-mile access – including for the poorest and most marginalized – is essential to ensure effective coverage and leave no one behind.
Germany’s leadership during its G7 Presidency in 2022 and through its continued partnership with mechanisms like Gavi and the Global Fund has had a key role in advancing this agenda, working towards more equitable access to and delivery of health innovations.
Through first-hand testimonies from partner countries, panelists will discuss how strong and coordinated collaboration among global health organizations with the support of global health leaders like Germany can stand up to unprecedented challenges.
The session will highlight how we can maximize impact by building on the investments made in the last two decades, better support regional capacities and continue strengthening health systems. By reinforcing inclusive, resilient and sustainable systems for health, we can ensure early detection and control of outbreaks and the deployment of vaccines, diagnostics and treatments for current and future epidemics.
People can utilize YouTube to learn from health experts and accredited organizations who have developed the skills to connect at scale with engaging and helpful information. YouTube Health’s mission is to make public health truly public, for the platform’s 2 billion users. This begins with revolutionizing the way people engage, interact, and receive accessible health information via video. Now, we’re looking to inspire the healthcare industry & professionals alike, to contribute towards the greater mission. WHS convenes key stakeholders at a global scale. Through panels and/or workshops, the YT Health is joining forces with the World Health Summit and WHO to build upon the following central topics: Accelerating Progress Towards Universal Health Coverage & Harnessing the Power of Digital Technologies for Global Health.
The socio-ecological model of public health considers the physical, social, and economic determinants of health at both individual and population levels. It emphasizes multiple interventions across diverse settings, from families to workplaces to government policies and services. This comprehensive approach recognizes that individuals are embedded in a larger society or environment, which is foundational for better health outcomes. The model encourages collaboration between stakeholders, including community members, organizations, policy makers and researchers to holistically address problems. It promotes the use of data collected from multiple sectors to gain a more complete understanding of any given issue.
An expanded socio-ecological model with a broadened continuum of care is a common, coherent framework to help us shift from selecting the competing right approaches to fostering the right outcomes. Understanding and managing health from an interspecies point of view calls for the awareness of similarities between the needs of different living things and limitations to meeting those needs in the shared environment. The expanded socio-ecological model is the shared foundation of efforts to protect health, ensure equitable and sustainable development and protect Earth’s biodiversity for the benefit of all species and generations.
The goal is to implement effective and fit for purpose surveillance systems in European countries with strong international and inter-institutional co-operation. The European Commission, the European Centre of Disease Prevention and Control (ECDC) and EU/EEA Member States are currently defining the concrete implementation of the European surveillance strategy, such as the list of communicable diseases, case definitions, a revamped digital platform for surveillance, EU reference laboratories as well as stronger international co-operation on epidemic surveillance in particular with the African Center for Disease Prevention and Control (African CDC).
This event will call on global, regional, and national leaders to prioritize children’s health and well-being by leveraging and mobilizing political and financial commitments to strengthen community-based health and nutrition programs to secure the right to survive and thrive for every child. Achieving this ambition requires strong, resilient, and inclusive primary health care systems, appropriately resourced and grounded at community level.
With the start of the COVID-19 pandemic, refugees and other migrants have had additional vulnerabilities and barriers to accessing health information, health care, education, social care, and other support services. Young refugees, especially refugee girls and stigmatized/marginalized refugee youth groups have been among the most vulnerable. This age group is also important because the proportion of children and young people is usually higher among forcibly displaced populations, when compared to general populations.
Worldwide, innovative technologies are increasingly being used to improve services for refugees and conflict-affected populations. These technologies offer great potential for improving efficiency, reducing costs, permitting rapid scalability of essential services, and reaching out to more vulnerable and stigmatized/marginalized groups, such as young girls and women, out-of-school youth, youth working in difficult conditions, youth living with chronic conditions and disabilities, as well as other disadvantaged young people that struggle with health information and healthcare access.
This panel of speakers will discuss how digital health technologies can be used to promote health in humanitarian and forced migration settings, the effect of youth-adult partnerships, youth participatory and co-design approaches, and social media tools on engaging youth in health education and promotion work in countries affected by forced migration and how digital divide and inequalities can be decreased in these settings.
Key population and groups are still left behind (sex workers, MSM, people who inject drugs and transgender people), and accounted for an estimated 65% of new HIV infections globally in 2020, because they often lack access to the full HIV prevention tools. In Sub Saharan Africa, 517 girls acquire HIV every day and 85% of new HIV infections are in young people aged 15-19. Women and girls accounted for 46% of all new infections in 2022. Gender inequality also contributes to the spread of HIV. It can increase infection rates, and reduce the ability of women and girls to cope with the epidemic.
The session highlights the challenges of stigma, discrimination and inequalities in the global fight and what we must do to end the epidemic for everyone, everywhere.
Disruptions to health systems and diversion of resources caused by the COVID-19 pandemic have also worsened the outlook, resulting in an increase in TB deaths and disease for the first time in a decade. Furthermore, growing drug resistance continues to compound the challenge of TB. Nevertheless, there are many encouraging developments in the field of TB, and this event will highlight examples and opportunities of innovation and collaboration to end TB across the continuum of care.
It will bring together a variety of stakeholders ranging from TB survivors, advocates, academics, civil society and community leaders, donors, the private sector, and technical partners. Speakers and participants will reflect on the commitments made at the HLM, discuss challenges ahead, and offer perspectives on the way forward in the global fight against TB.
Despite its potential, a health-focused framing in current climate discussions is exceedingly rare. In order to move forward different UN agencies and cross-sectoral stakeholders have to jointly address ongoing and emerging crosscutting issues, taking into account the interactions between climate change, biodiversity loss and health at all stages of the negotiation process. Creating a common narrative and vision from the various silos of "Planetary Health," "One Health," and "Climate Change and Health" must be on the agenda to join forces and powerfully bring out the best for global health in the ongoing political discussions by establishing a global health lens.
The strengthening of the Alliance for Transformative Action on Climate and Health (established at COP26) and the WHO Health Pavilion at COP27 is urgently needed, and concepts like Planetary Health and One Health have to be included in international collaborative mitigation and adaptation strategies. Only reshaping the governance and the economics of global climate and health policy while putting a focus on an equity-based approach will pave the way for a healthy green transformation worldwide. Next steps will have to include the construction of climate-resilient and sustainable low carbon health systems that consider the health sector as a guide in shaping an effective response to environmental health challenges.
This is a topic to which citizens can immediately relate to and care for and where international collaboration can clearly add value, momentum – and results. The session will recognize the need for approaches that are both ambitious and pragmatic, with a clear operational path to deliver prevention and achieve healthy living, achieving the results that have elude us thus far. The session will also address barriers to introducing mandatory legislation and policies such as taxation, labelling and marketing restrictions or the MPOWER technical package to reverse the tobacco epidemic.
In the run up to the Fourth UN High Level Meeting on non-communicable diseases in 2023, urgent interventions are needed to take us to Agenda 2030, along with long-term more generational components, including commercial determinants, that have a longer time horizon. An effective approach to prevention and promotion should start with families, children and young people. It should also be comprehensive, covering dimensions such as access to promotion and prevention, vaccination and care; improved nutrition and physical activity; protection from tobacco and alcohol, and the commercial determinants of health; safeguard of children’s mental and physical health from novel digital risks, such as influencers pushing unhealthy food, alcohol or tobacco products, social media pressure, or cyberbullying. Promoting such a package of coordinated action would increase the communication potential and multiply the impact as need.
Such holistic approach would be anchored in practical instruments. In many of these areas, excellent practices already exist and countries can be clustered in the teams and supported to better adjust and replicate the best approaches. Conversely, in the topics for which gaps exist, joint work should aim at designing innovative, system-wide approaches. This should aim in raising the bar for all instead of settling for the minimum common denominator.
The Lancet One Health Commission plays a pivotal role in fostering awareness about One Health and the societal challenges we confront. They actively contribute to the generation of new knowledge in this field through research endeavors and recommendations for One Health implementation at different levels. The One Sustainable Health (OSH) for All Foundation established six international working groups that addressed key areas where One Sustainable Health practices are needed. These include: pollution, food and nutrition systems, community action, wildlife and ecosystems, and financing and governance for One Sustainable Health.
The outcome of their collaborative efforts was presented at the “OSH Forum 2023” in Lyon this July. In light of the progress made, a proposal for the establishment of a "One Sustainable Health Institute," at the initiative of Europe, is advanced for consideration.
It is essential to provide girls and women in LMICs with accurate information in order for them to lead healthy lives, promote sexual and reproductive health (SRH) and well-being and improve their access to health services. Finding new and better ways to reach girls and women matters, because we know that unplanned or unwanted pregnancies can lead to major health risks for both mothers and their babies, as well as reduced access to social and economic opportunities.
Bayer has dedicated itself to help provide 100 million women in LMICs yearly with modern contraception by 2030, in line with the UN Sustainable Development Goals. But a company cannot achieve a goal like this alone, and innovations are needed for true success. Together, we need to find data-driven and scalable approaches. What are the key strengths of these innovations and where are the gaps? We are at the dawn of the possibilities that digital innovations and AI can offer.
COP28 in Dubai, the UAE, represents a critical inflection point in responding to these growing threats, including by delivering solutions to accelerate the global energy transition, and building bridges to advance global efforts that will support the Global South and countries that are most vulnerable.
The delivery of the first Global Stocktake will be one of the main legacies of COP28, and a crucial process to drive further ambition, sectoral action, cooperation, and support in this decade and beyond.
Health can be a powerful argument for increased ambition at COP28 and in the Global Stocktake; for example, the economic case for climate action makes clear that the health benefits far outweigh the costs of meeting the Paris goals. The concrete and measurable potential of climate commitments to protect lives, health and wellbeing of global populations would be a powerful benchmark of progress, and would motivate further action.
One of the core ambitions for the WHO Immunization Agenda 2030 (IA2030) is to expand immunization services beyond infancy to include the whole life course and ensure “a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and well-being”. To achieve these goals, strategies will be crucial to build and sustain robust routine immunization programs for all ages.
Amidst evolving epidemiology, the impending winter season and the WHO declaring an end to the emergency phase of the COVID-19 pandemic, this session explores the critical importance of sustained prioritization of immunization across the life course, to help protect population health and reduce the burden of vaccine-preventable respiratory diseases on health systems and economies.
Experts will focus on the practical measures needed to firmly embed life course immunization: the role of health care workers in building vaccine confidence; appropriate National Immunization Technical Advisory Group (NITAG) composition and how pharmacists can improve access and simplify pathways.
This session will be interactive and enable discussion on research findings and how they relate to IA2030.
Recent reports from the WHO, UNICEF, and the Missing Billion Initiative are very clear: the Sustainable Development Goal of achieving Universal Health Coverage is not attainable if we do not urgently bridge the health gap experienced by persons with disabilities and provide access to assistive technology to all those who need it.
In this interactive session, we invite global health actors to learn about this urgent issue and explore together concrete actions that make health systems more inclusive. Voices from persons with disabilities and assistive technology users will be at the center. As evidence of inclusive health in practice, we will showcase progressive health strategies carried out at national level. We will also discuss how community-based approaches to inclusive health and stronger collaboration of global health actors can accelerate the progress to UHC.
YPL are selected via a process of nomination by their national academies or M8 Alliance members. To date, the YPL network of alumni includes more than 240 leading young medical professionals, over 50% of whom are from countries in the global South. Immediately prior to this WHS, members of the 2023 cohort were convened to reflect on challenges faced when leading in professional situations and the very nature of what it takes to be a leader in the world today. The cohort has been mentored by experts, but perhaps most uniquely they had the chance to share and learn from each other’s experiences.
During this session, members of the 2023 cohort will present their insights about the challenges and opportunities for leadership from their workshop immediately prior to the WHS as well as from their diverse career experiences and share their recommendations about how to promote leadership for improved health and healthcare locally, nationally and globally. There will be designated time for contributions from the audience during which participation is encouraged, especially from other young medical professionals.
IAP brings together some 150 national, regional and global academies of science, medicine and engineering that work together to advance evidence-based policies, improve public health, promote excellence in science education, and achieve other critical development goals.
For more information about IAP see www.interacademies.org and follow IAP on Twitter twitter.com/IAPartership , LinkedIn linkedin.com/company/interacademypartnership and YouTube tinyurl.com/IAPyoutube
We will look to see how the world coalesces to overcome viral challenges. It is an opportunity to take a deeper look at the concept of a one-world vaccine library which could harness recent scientific advances, including immunogen design and prototype vaccines, with clinical data for major viral families. Undertaking and bolstering global research and development, with an equity-driven ambition, could potentially transform future global responses to emerging disease outbreaks.
We will elaborate on the imperative to establish global and geo-diversified partnerships to strengthen pandemic prevention, preparedness, and response, including enhancing regional clinical trial and manufacturing ability. Additionally, to ensure a globally coordinated response, the discussion will also identify the distinct roles different stakeholders and sectors in the global health ecosystem, and beyond, will need to play to enable the Mission's success.
Ultimately, our panel of experts will delve into the various aspects of preparedness and partnerships necessary for the 100 Days Mission. Critically it will explore the essential investments that are required now, and not later, to ensure prompt execution of the 100 Days Mission – and the days thereafter – when the next viral threat emerges.
This session will provide an insight into the themes that will be explored at the World Health Summit Regional meeting, to be hosted by Monash University in Melbourne in April 2024. The Melbourne regional meeting will focus on;
• Thriving Communities: Living well and living well together: An understanding of the intersecting medical, health, technological and systemic social issues we face - and the solutions we need to address them.
• Geopolitical Challenges: Protecting health across borders: Everyone has the right to a safe, just and equal world - to live in freedom, peace and security. Delegates will explore the impact of geopolitical insecurity, armed conflict and major disruptions to populations.
• Climate Change & Health: How health responds to the climate emergency: Addressing the challenges and mitigating the consequences of climate change on human health outcomes and planetary health is an urgent priority and core focus for our region.
This session will explore the impact of these three themes, with a strong focus on public health issues directly affecting the South-East Asia and the South Pacific region.
We want to shed light on the economic environment of antibiotics research and development and discuss the various concrete options for scaling up activities in this field. One interesting aspect of them is that only their combination will achieve the necessary scale to create the economic basis for a sustainable pipeline of new antibiotics.
To leverage the power of youth in strengthening global health security and promoting healthier communities, the International Pharmaceutical Students' Federation (IPSF) and the International Federation of Medical Students' Association (IFMSA), as leading young health professional organizations, are planning a session during the World Health Summit 2023 to reflect on the outcomes of the High-Level Meetings on UHC, Pandemic Preparedness and Response and Tuberculosis.
The session will specifically focus on sharing critical perspectives and the vision of youth in accelerating progress towards Universal Health Coverage and harnessing the power of innovation and technologies for Global Health Security, which are central topics in achieving health equity. The urgency for digital transformations in global health is a key concern for young people, and the session aims to bring together youth and stakeholders to brainstorm innovative solutions and crucial action points post-discussions at the High-Level Meetings during the United Nations General Assembly. The IPSF and IFMSA intend to reflect on how youth can be involved in the implementation process of the declarations and position them as active contributors to the achievement of Universal Health Coverage and the resilience of health systems.
This has largely been attributed to a ‘perfect storm’ of compounding and often intersection global challenges: the growing numbers and length of conflicts, severity and far-reaching impacts of climate change, and the current and growing risks of pandemics.
These “three Cs” exacerbate existing inequities: rendering marginalized women, children and adolescents, more marginalized and vulnerable to potential risk; and severely impacting their access to life-saving immunization and their socio-economic development. All of which are symptom of environments where systems are fragile, under resourced and inequitable.
Even where there has been progress, it has not been distributed equally within and between regions, countries, communities, and households. Where a child, adolescent and woman live, should not determine whether they just survive or have a chance to thrive. Equally, it is not enough to have services available, we must ensure quality essential services that are accessible and affordable.
This plenary will set the tone and be a rallying call to all participants to centralize populations facing greatest inequities in health access and social, economic and health outcomes. As we have just concluded the UN High-Level meeting on UHC, let us put the universal – the equity- back into health coverage.
The event will showcase accelerated efforts and commitments from global and country partners on advancing the rights and opportunities of women, children and young people. It will further discuss how new models of co-investments and partnerships can help address the scale of development challenges affecting women, girls, and adolescents and addressing the root causes of inequality.
Presently, less than one percent of vaccines administered on the continent are manufactured locally. This places a great burden on the health systems of African countries and reduces their ability to respond to pandemics and other health crises.
The overall goal is to enable Africa to manufacture 60 percent of its vaccine needs locally by 2040.
The implementation of these bold programs will be Africa-led, with support from the global system, and will demand that key stakeholders and implementation partners including governments, manufacturers, national regulatory authorities, donors, and funders, work in a coordinated manner.
This workshop session will bring together key stakeholders and collaborators in the Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action to reflect on progress to date and to discuss remaining challenges as part of the ongoing dialogue in the field.
Each speaker will give a short Pitch (5-7 min each, 1 question each for clarifications, no one more than 10 min) on questions relating to the inter-sectoral collaborations already in place or still required, depending on the area on the roadmap of the Action plan they feel they can best represent.
We will have participants representing African manufacturers-to be, Industry, Funders, Market analysts, Academia, discussing the needs for training and capacity building.
A moderated panel discussion will follow the presentations where the panel members can interact with each other and address questions from the audience.
COVID-19 has put the spotlight on the weaknesses of health systems across the world. These include a lack of sustainable financing, skilled workforces, access to diagnostics, medical equipment and therapies, and ability to leverage the private sector to support a coordinated response.
Breaking silos between the public, private, academic, and other sectors is crucial to address the world’s most pressing needs and create lasting positive change. When it comes to health and healthcare, engaging stakeholders in new models of public-private collaboration is key to identify and scale up solutions for more resilient, efficient, and equitable healthcare systems to keep populations healthy and deliver the best care.
There needs to be a major shift in the way sectors work together to finance potentially scalable solutions to the development and delivery of quality healthcare and medicines, especially for low-income populations.
The session will bring together perspectives of researchers, public health institutes and policy makers and encompass perspectives ranging from infectious diseases to health systems and implementation research.
The session will be hosted by the German Alliance for Global Health Research (GLOHRA), an initiative to promote networking and strengthen global health research in Germany. It is an association of global health researchers from all disciplines affiliated with public research institutions across Germany and funded by the German Federal Ministries for Education and Research as well as the German Federal Ministry for Economic Cooperation and Development.
This session will explore opportunities for alternative solidarity mechanisms to compensate actors and fairly share benefits resulting from scientific discovery and contributions to innovation, ultimately enhancing resources available for early detection and warning. Panelists will discuss whether such an approach to benefit-sharing can support ongoing multilateral discussions, and options to make this a robust and effective tool to improve our collective health security.
The session will briefly introduce the extent of the burden of poor mental health, and spotlight solutions and the path to their equitable implementation. It will consider what policy makers need from innovation to develop and implement effective strategies globally, regionally or nationally; and showcase case studies of effective and promising interventions. The session will also consider what action is needed to make this vision a reality, including centering lived experience in designing effective technical and policy solutions.
Lack of women’s inclusion in all stages of the design and development of innovations in global health leads to gender-blind solutions. Inadequate investment in research and innovation to address the needs of women and girls in all their diversity leads to a gap in solutions addressing women’s health. An equitable future can only be achieved if advances in science and technology include and address the needs of all. Together, we can change this.
To ensure a world of infinite opportunities for all, UNFPA together with inaugural members will launch the Equity 2030 Alliance in this year’s World Health Summit. To normalize gender equity in health science and technology, the Alliance accelerates transformative norms and principles and introduces data-driven arguments and strategies for closing the gaps in women-focused and gender-inclusive health solutions in science, technology, and financing by 2030. Creating gender-equitable solutions results in greater equality, leading to advanced women’s health, and economic growth for individuals, communities, businesses, and states.
The world is not designed for women. Let us redesign it.
The session will include opening remarks by the Executive Leadership of UNFPA and by the Co-Championing Member State representatives, followed by a moderated panel discussion with the distinguished representatives of the Equity 2030 Alliance inaugural members.
The event is co-sponsored by Bayer AG.
International cooperation and partnership between national health authorities, the UN, patient advocacy groups, medical societies, academia, and the private sector is needed to support national efforts in cancer control planning and implementation. Components of cooperation are training and R&D in cancer prevention, early detection, treatment, palliative care. Global capacity building for cancer research such as for clinical trials is key to advance progress in cancer treatment.
In this session, we will discuss how the vision of cross sector partnerships can be put into practice. To enrich the discussion we will present successful models of cooperation such as the hospital partnership program of the German Ministry of Cooperation (BMZ) and the Charité iSTARC program for global virtual tumor conferences.
This session will explore the challenges to ensuring holistic services to women and outline how gender-sensitive healthcare policies, interventions, and research can disrupt the current approach and prioritize women's health concerns while ensuring equitable access to healthcare services. The discussion will highlight the importance of taking a holistic and inclusive approach that considers social determinants of health, promotes gender equity, and leverages technology and innovation to improve women's health outcomes. The panel will explore innovative strategies and interventions that have been successful in addressing women's health needs and discuss policy changes necessary that are gender-sensitive and responsive to the unique health needs and perspectives of women and girls.
Recognizing that people have multiple, often fragmented interactions with the health systems, the session will focus on the challenges of providing quality, sustainable NCD care as a true test of UHC. Chronic NCDs, like diabetes, require constant interactions with various elements of the health system. Integrating effective NCD care is one of the best building blocks for creating sustainable and resilient health systems.
A diverse line-up of advocates, health finance experts, providers, and technical partners will present their unique perspectives on making UHC a reality in low- and middle-income countries by shaping health markets, bringing care closer to home, and supporting people living with chronic conditions. By leveraging renewed momentum and centering the voices of those living with NCDs and those providing NCD care, we will emphasize the need for community-centered approaches to increase access to health care on the path to sustainable, equitable coverage for all.
The outcomes of the UN High-level Meeting on Pandemic Prevention, Preparedness, and Response (Pandemic PPR) in September 2023 as well as key deliberations of the G7 and G20 will be a leading guide on the next steps to advance action. The negotiation for a pandemic accord – focused on equity and access – as well as the revisions of the International Health Regulations will be critical steps in this process. Significant investment and new types of financing are required.
To combat future existential risks, the Pandemic PPR agenda must be taken beyond the health sector and make resilience a priority at the government and societal level, with broad stakeholder involvement and a focus on communities. Financing must be secure, the ownership of the Pandemic PPR agenda needs to be truly inclusive, and accountability needs to be assured.
Together we will have a closer look into the factors behind the success stories and the critical junctions of WHO in the past, will explore the current future challenges expectations and will imagine a future, in which people can live healthy, productive lives, regardless of who they are or where they live.
In the 75-year history of the World Health Organization, WHO has made important progress in improving health for all worldwide. Nevertheless, there is still a long way to go before the health-related goals of the 2030 Agenda are achieved. On this challenging journey in times of multiple crises and geopolitical divides, WHO has developed new partnerships and cooperation with a wide range of sectors.
Collaboration is at the heart of engagement of the World Health Organization. Partnerships with member states, international and regional organizations, parliamentarians as well as non-state actors are essential for WHO to effectively deliver on the WHO’s Triple Billion Targets. Initiated by Ghana, Norway and Germany in 2019, the SDG3 Global Action Plan is a platform for improving collaboration among the biggest players in global health.
There have been huge advances in the tools and technologies to tackle women’s cancers: we can prevent cervical cancers through vaccination; we can detect cancer early through screening and early detection, reinforced by education; we can treat breast and cervical cancer early when there is more chance of success. But access to diagnostics, treatment and care are lacking in most low- and middle-income countries, in addition to social, cultural, economic and political barriers, meaning too many women are dying from preventable and treatable cancers.
Deep inequities in access to vaccination, early detection screening and treatment – in high- and low-middle-income countries – mean survival is worse in some communities than others: low health literacy and education stop many women seeking or receiving care; many have to pay for services themselves; and, in many countries, women’s cancers and other conditions impacting women are managed by separate parts of health systems, with no holistic view of women’s needs – leading to healthcare opportunities being missed. Additionally, women make up to 70% of health workers, providing vaccination, screening and treatment, yet they face unsafe working conditions and are excluded from decision making, impacting the cancer care they are able to provide.
There are great examples of initiatives in different countries that help women avoid and survive cancer. How can we ensure there is sufficient policy vision? Our expert panel will debate this topic.
German Government's global health strategy (2020) describes Germany`s commitment and expertise to current challenges. Within global health, now many activities are observed with regard to academic partnerships as well.
However, compared to neighboring European countries, Germany has few structures and qualified scientific personnel in the field of global child health. This makes it difficult systematically and scientifically addressing relevant issues. Partnership-based research and teaching oriented towards the needs of resource-poor countries is limited and to date there is no institute for global child health in Germany.
In the political sphere, there is currently a partnership focus on Africa - also in the area of health. Especially in countries in Sub-Saharan Africa, the greatest burden of disease currently lies with children.
There is a need of partnerships that jointly strengthen good clinical research as well as teaching and training of local health workers, thereby also improve the long-term health of vulnerable groups such as children.
For these reasons, we are using child health as an example in our session to shed light on the success of academic cooperation in general.
The speakers will present various models of innovative academic cooperation between German institutions and their partners in resource-poor countries. Our discussion focuses on needs in the partner countries, sustainability and improving the health of vulnerable groups through the academic partnerships.
Therefore, in January this year Europe has launched the four Testing and Experimentation Facilities for AI and Robotics in the domains Healthcare, Smart Cities, Agriculture and Manufacturing. We put into focus potential and responsibilities in testing AI solutions (software and hardware) in large-scale and sustainable virtual or real environments; evaluation activities that facilitate market access for these trustworthy intelligent technologies, particularly by considering new regulatory requirements (certification, standardization, code of conduct, etc.), and ensuring easy access to these evaluation resources (e.g., link with health data sources).
The panel session at the World Health Summit 2023 will also discuss the Global Initiative on AI for Health (GI-AI4H), which has been announced on July 6, 2023, by ITU, WHO, and WIPO. The panel will also explore the role of ITU, WHO, and WIPO in promoting responsible healthcare AI by providing governance, standards, facilitating knowledge sharing, and supporting evidence-based implementation to address global health challenges and enable AI adoption in healthcare.
Because of time pressure journalists with no or insufficient training in health sciences and policy have used dubious sources of information, f. e. untrustworthy social media posts, which have led to misinformation, miscommunication and distrust amongst communities. Publishing houses have furthermore missed to invest in international health reporting due to tight budgets and different reporting preferences. Besides, the lack of sustainable communication and cooperation between science, media and policy has further aggravated accurate health reporting.
The panel will explore which challenges journalists around the world have been facing during the past health crisis, which support structures might be needed to train them and which international global health reporting grants could serve as a financial source for comprehensive research. It will also explore ways for science and media to bridge the current gap in communication and for media and the corporate sector to benefit from each other.
Despite the evident need for healthcare services by people living with NCDs, exogenic factors such as distance, costs, mobility, displacement and emergencies negatively affect service delivery, hindering appropriate access. Apex of this negative influence by external factors was the COVID-19 pandemic. It worsened the situation, as - physical - access to health services was limited and facilities were preoccupied with COVID-19 treatment. Furthermore, most NCD patients were forced to stay home as they were considered be at a higher risk. Beyond stress and anxiety, this also created a backlog for diagnosis and treatments.
However, these challenges have also functioned as a positive catalyzer and led to a never seen before development of digital health innovations. NCDs and its patients represent a core beneficiary group from this thrust of innovation. In order to fully benefit from this promising future, not only partnerships between governments / policy-makers and the private sector, academia, IT specialists, civil society and other relevant stakeholders are crucial, but also changes to the policy frameworks are required.
The panel will reflect on recent experiences, best practices and future opportunities and discuss possible suggested ways forward.
This commissioned Lancet Series on Work and Health aims to address this gap. It identifies six changing themes in the world of work from the impact of technology on the nature of work in High-Income Countries, culminating in the COVID-19 pandemic’s sudden shift to telework to the looming threat of climate change’s effects on work and explore work as a social determinant of health, with a focus on mental health and an inclusive workforce. This session will feature presentations from the authors, and a panel discussion and Q&A to explore the key message of the Series – that work is an undervalued lever for improving population health. Major gains in population health and reduced health disparities can be realized by an increased focus on improving the work environment.


